Group One Trading
HCAT icon

Group One Trading’s Health Catalyst HCAT Stock Holding History

Group One Trading’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Sell
600
-200
-25% -$289 ﹤0.01% 7146
2026
Q1 		$1.02K Buy
+800
New +$1.5K ﹤0.01% 7212
2025
Q3 		– Sell
-2,000
Closed -$7.54K – 8683
2025
Q2 		$7.54K Hold
2,000
– – ﹤0.01% 6890
2025
Q1 		$9.06K Buy
+2,000
New +$10.6K ﹤0.01% 6329
2024
Q2 		– Sell
-2,200
Closed -$16.6K – 7032
2024
Q1 		$16.6K Buy
+2,200
New +$20.1K ﹤0.01% 5561
2022
Q4 		– Sell
-800
Closed -$8K – 7570
2022
Q3 		$8K Buy
+800
New +$10.6K ﹤0.01% 6627
2022
Q1 		– Sell
-100
Closed -$4K – 8278
2021
Q4 		$4K Hold
100
– – ﹤0.01% 7699
2021
Q3 		$5K Sell
100
-500
-83% -$27.3K ﹤0.01% 7732
2021
Q2 		$33K Buy
600
+100
+20% +$5.33K ﹤0.01% 6893
2021
Q1 		$23K Hold
500
– – ﹤0.01% 6701
2020
Q4 		$22K Buy
500
+300
+150% +$11.1K ﹤0.01% 5466
2020
Q3 		$7K Hold
200
– – ﹤0.01% 5532
2020
Q2 		$6K Buy
+200
New +$5.53K ﹤0.01% 5307

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's HCAT Position: Q2 2026 in Review

Group One Trading opened a new position in Health Catalyst (HCAT) in Q2 2026: 190 shares worth $378. The stake represents ﹤0.01% of the portfolio and ranks #7334 among its holdings. This is a return to the name: Group One Trading previously reported a position in HCAT as recently as Q4 2025.

Group One Trading first reported a position in HCAT in Q1 2020 and has held it in 10 quarters since. The position peaked at $116K in Q3 2022. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Group One Trading held 190 shares of Health Catalyst worth $378 as of Q2 2026.
  • Health Catalyst was a new Group One Trading position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7334 holding.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and has held it in 10 quarters since.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.